BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$1.48
-0.15 (-9.20%)
As of Aug 8, 10:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
127.89M
Net Income
17.99M
Gross Margin
71.5%
Profit Margin
14.1%
Rev Growth
+5.2%
D/E Ratio
9.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 127.89M 121.54M 22.38M 21.94M
Gross Profit 91.39M 86.85M 7.24M 7.09M
Operating Income 23.66M 20.24M 3.89M 4.25M
Net Income 17.99M 15.39M 3.27M 4.37M
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Rev Growth +5.2% +5.2% -5.1% +24.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 25.04M 25.04M 11.22M 12.91M
Total Equity 2.77M 2.77M 63.17M 61.05M
D/E Ratio 9.02 9.02 0.18 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 24.98M 22.56M 5.70M 5.36M
Free Cash Flow 2.62M 2.18M